Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Douxfils

Showing results (1-10 of 221) with videos related to

Pageof 23
Sort By:
Frontiers in Endocrinology|June 27, 2025
Cost-effective screening strategy to prevent venous thromboembolism in combined oral contraceptive usersJonathan Douxfils
The Journal of Infection|July 7, 2021
Importance of sample dilution in the evaluation of the antibody response after SARS-CoV-2 vaccinationJulien Favresse, Jonathan Douxfils
Journal of Clinical Microbiology|March 24, 2021
Evaluations of SARS-CoV-2 Serological Assay Performance Need Inclusion of Long-Term SamplesJulien Favresse, Jonathan Douxfils
Frontiers in Cardiovascular Medicine|July 30, 2025
Commentary: The ETP-based APC resistance assay remains the gold standard for evaluating the APC resistance phenotype in users of combined oral contraceptivesLaure Morimont, Jonathan Douxfils
American Journal of Hematology|May 1, 2020
Ecarin based coagulation testingRobert C Gosselin, Jonathan Douxfils
Methods in Molecular Biology (Clifton, N.J.)|August 15, 2017
Measuring Direct Oral AnticoagulantsRobert C Gosselin, Jonathan Douxfils
Seminars in Thrombosis and Hemostasis|March 2, 2017
Laboratory Assessment of Direct Oral AnticoagulantsJonathan Douxfils, Robert C Gosselin
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Critical Considerations in the Interpretation of Bone Turnover Marker Data in Hormonal Contraceptive Users. Comment on Tassi et al. Hormonal Contraception and Bone Metabolism: Emerging Evidence from a Systematic Review and Meta-Analysis of Studies on Post-Pubertal and Reproductive-Age Women. <i>Pharmaceuticals</i> 2025, <i>18</i>, 61Jonathan Douxfils, Jean-Michel Foidart
Biomed Research International|June 17, 2015
Target-Specific Oral Anticoagulants-New Approaches in the Field of Oral AnticoagulationHelen Mani, Jonathan Douxfils, Jack Ansell
Methods in Molecular Biology (Clifton, N.J.)|May 19, 2023
Evaluation of Activated Protein C Resistance Using Thrombin Generation TestJonathan Douxfils, Céline Bouvy, Laure Morimont
Pageof 23

Showing results (1-10 of 221) with videos related to

Sort By:
Pageof 23
Frontiers in Endocrinology|June 27, 2025
Cost-effective screening strategy to prevent venous thromboembolism in combined oral contraceptive usersJonathan Douxfils
The Journal of Infection|July 7, 2021
Importance of sample dilution in the evaluation of the antibody response after SARS-CoV-2 vaccinationJulien Favresse, Jonathan Douxfils
Journal of Clinical Microbiology|March 24, 2021
Evaluations of SARS-CoV-2 Serological Assay Performance Need Inclusion of Long-Term SamplesJulien Favresse, Jonathan Douxfils
Frontiers in Cardiovascular Medicine|July 30, 2025
Commentary: The ETP-based APC resistance assay remains the gold standard for evaluating the APC resistance phenotype in users of combined oral contraceptivesLaure Morimont, Jonathan Douxfils
American Journal of Hematology|May 1, 2020
Ecarin based coagulation testingRobert C Gosselin, Jonathan Douxfils
Methods in Molecular Biology (Clifton, N.J.)|August 15, 2017
Measuring Direct Oral AnticoagulantsRobert C Gosselin, Jonathan Douxfils
Seminars in Thrombosis and Hemostasis|March 2, 2017
Laboratory Assessment of Direct Oral AnticoagulantsJonathan Douxfils, Robert C Gosselin
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Critical Considerations in the Interpretation of Bone Turnover Marker Data in Hormonal Contraceptive Users. Comment on Tassi et al. Hormonal Contraception and Bone Metabolism: Emerging Evidence from a Systematic Review and Meta-Analysis of Studies on Post-Pubertal and Reproductive-Age Women. <i>Pharmaceuticals</i> 2025, <i>18</i>, 61Jonathan Douxfils, Jean-Michel Foidart
Biomed Research International|June 17, 2015
Target-Specific Oral Anticoagulants-New Approaches in the Field of Oral AnticoagulationHelen Mani, Jonathan Douxfils, Jack Ansell
Methods in Molecular Biology (Clifton, N.J.)|May 19, 2023
Evaluation of Activated Protein C Resistance Using Thrombin Generation TestJonathan Douxfils, Céline Bouvy, Laure Morimont
Pageof 23